91 related articles for article (PubMed ID: 6274906)
1. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.
Lamberts SW; Timmers JM; Oosterom R; Verleun T; de Jong FH
J Clin Endocrinol Metab; 1982 Feb; 54(2):450-4. PubMed ID: 6274906
[TBL] [Abstract][Full Text] [Related]
2. Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin.
Tucci JR; Zäh W; Kalderon AE
Am J Med; 1973 Nov; 55(5):687-94. PubMed ID: 4356100
[No Abstract] [Full Text] [Related]
3. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.
Kennedy L; Traub AI; Atkinson AB; Sheridan B
J Clin Endocrinol Metab; 1987 Jun; 64(6):1320-2. PubMed ID: 3106399
[TBL] [Abstract][Full Text] [Related]
4. Plasma steroids in two subjects with ovarian androgen-producing tumors arrhenoblastoma and gynandroblastoma.
Laatikainen T; Pelkonen R; Vihko R
J Clin Endocrinol Metab; 1972 Mar; 34(3):580-5. PubMed ID: 4334770
[No Abstract] [Full Text] [Related]
5. [Endocrinological study of Sertoli-Leydig cell tumor].
Haruyama Y; Miyakawa I; Inoue H; Mori N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):765-70. PubMed ID: 2955060
[TBL] [Abstract][Full Text] [Related]
6. [Combined dexamethasone suppression and chorionic gonadotrophin stimulation test in the diagnosis of androgenic functional ovarian tumors].
Lehmann WD; Lauritzen C
Geburtshilfe Frauenheilkd; 1972 Nov; 32(11):913-21. PubMed ID: 4345633
[No Abstract] [Full Text] [Related]
7. [Endocrine studies in a case of arrhenoblastoma (author's transl)].
Saito K; Tamada K; Nishimura Y; Yamabe H; Koori Y; Inatome T; Fujiwara T; Katayama K; Morikawa H
Nihon Naika Gakkai Zasshi; 1982 Mar; 71(3):331-9. PubMed ID: 6286811
[No Abstract] [Full Text] [Related]
8. Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment.
Valenca MM; Negro-Vilar A
Endocrinology; 1986 Jan; 118(1):32-7. PubMed ID: 3000742
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hyperthecosis in the adolescent patient.
Wentz AC; Gutai JP; Jones GS; Migeon CJ
J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
[TBL] [Abstract][Full Text] [Related]
10. [Hirsutism].
Laatikainen T
Duodecim; 1975; 91(7):483-90. PubMed ID: 166814
[No Abstract] [Full Text] [Related]
11. [Morphological and endocrinological study of ovarian arrhenoblastoma (author's transl)].
Takakura K; Okamura H; Aso T; Takenaka A; Matsuoka M; Kanzaki H; Suzuki A; Nishimura T
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):961-8. PubMed ID: 6272528
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effect of gonadotropin-releasing hormone and its agonist analog (HOE766) on in vitro testosterone production by purified rat Leydig cells.
Browning JY; D'Agata R; Steinberger A; Grotjan HE; Steinberger E
Endocrinology; 1983 Sep; 113(3):985-91. PubMed ID: 6409594
[TBL] [Abstract][Full Text] [Related]
14. A gonadotropin-responsive adrenocortical adenoma.
Givens JR; Andersen RN; Wiser WL; Coleman SA; Fish SA
J Clin Endocrinol Metab; 1974 Jan; 38(1):126-33. PubMed ID: 4358642
[No Abstract] [Full Text] [Related]
15. Leydig cell cooperation in vitro: evidence for communication between adult rat Leydig cells.
Hedger MP; Eddy EM
J Androl; 1990; 11(1):9-16. PubMed ID: 2155894
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
17. Individual 17-ketosteroid excretion in a case of arrhenoblastoma and its response to corticotrophin and human chorionic gonadotrophin stimulation and to dexamethasone inhibition.
Louros NC; Batrinos ML; Carcatzoulis S
J Clin Endocrinol Metab; 1966 Jun; 26(6):645-50. PubMed ID: 4287988
[No Abstract] [Full Text] [Related]
18. Ovarian and peripheral steroid hormones in a case of Sertoli-Leydig cell tumor.
Mango D; Scirpa P; Liberati M; Menini E; Fabiano A; Mancuso S
J Endocrinol Invest; 1988; 11(7):521-5. PubMed ID: 2844882
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
Rosenthal SM; Grumbach MM; Kaplan SL
J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
[TBL] [Abstract][Full Text] [Related]
20. Androgen studies in a patient with lipoid-cell tumor of the ovary.
Osborn RH; Bradbury JT; Yannone ME
Obstet Gynecol; 1969 May; 33(5):666-72. PubMed ID: 4305119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
